0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Clostridial Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-24Q13345
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Clostridial Diseases Market Research Report 2023
BUY CHAPTERS

Clostridial Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24Q13345
Report
March 2024
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clostridial Diseases - Market

Clostridial diseases are the infectious condition in animals and humans resulting from Clostridium species. It is a bacterial infection usually found in soil and organic materials. The disease caused in cattle through punctured wounds and contaminated food, which trigger the various factors and damage body tissues activating latent spores, followed by very rapid multiplication in the animal's body with toxin production, causing death within hours. But it can spread through animal to animals. The toxin may cause neuronal dysfunction and gastrointestinal tract damage.
The global market for Clostridial Diseases was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Clostridial Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clostridial Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Clostridial Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Clostridial Diseases include Boehringer Ingelheim International GmbH, Zoetis, Elanco, Merck & Co. Inc, Phibro Animal Health Corporation, Virbac, Vetoquinol, HIPRA and Ceva, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Clostridial Diseases, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clostridial Diseases by region & country, by Type, and by Application.
The Clostridial Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clostridial Diseases.
Market Segmentation

Scope of Clostridial Diseases - Market Report

Report Metric Details
Report Name Clostridial Diseases - Market
Segment by Type:
  • Tetanus toxoid
  • Multivalent Vaccine
  • Antibiotics
Segment by Application
  • Humanity
  • Animal
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim International GmbH, Zoetis, Elanco, Merck & Co. Inc, Phibro Animal Health Corporation, Virbac, Vetoquinol, HIPRA, Ceva, Dechra, Kyoritsuseiyaku Corporation, Endovac Animal Health, Zydus Group, Indian Immunologicals Pvt. Ltd, UCBVET Saúde e Bem Estar Animal, American Reagent Inc, Neogen Corporation, Huvepharma, China Animal Husbandry Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Clostridial Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Clostridial Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Clostridial Diseases in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Clostridial Diseases - Market report?

Ans: The main players in the Clostridial Diseases - Market are Boehringer Ingelheim International GmbH, Zoetis, Elanco, Merck & Co. Inc, Phibro Animal Health Corporation, Virbac, Vetoquinol, HIPRA, Ceva, Dechra, Kyoritsuseiyaku Corporation, Endovac Animal Health, Zydus Group, Indian Immunologicals Pvt. Ltd, UCBVET Saúde e Bem Estar Animal, American Reagent Inc, Neogen Corporation, Huvepharma, China Animal Husbandry Group

What are the Application segmentation covered in the Clostridial Diseases - Market report?

Ans: The Applications covered in the Clostridial Diseases - Market report are Humanity, Animal

What are the Type segmentation covered in the Clostridial Diseases - Market report?

Ans: The Types covered in the Clostridial Diseases - Market report are Tetanus toxoid, Multivalent Vaccine, Antibiotics

1 Market Overview
1.1 Clostridial Diseases Product Introduction
1.2 Global Clostridial Diseases Market Size Forecast
1.2.1 Global Clostridial Diseases Sales Value (2019-2030)
1.2.2 Global Clostridial Diseases Sales Volume (2019-2030)
1.2.3 Global Clostridial Diseases Sales Price (2019-2030)
1.3 Clostridial Diseases Market Trends & Drivers
1.3.1 Clostridial Diseases Industry Trends
1.3.2 Clostridial Diseases Market Drivers & Opportunity
1.3.3 Clostridial Diseases Market Challenges
1.3.4 Clostridial Diseases Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clostridial Diseases Players Revenue Ranking (2023)
2.2 Global Clostridial Diseases Revenue by Company (2019-2024)
2.3 Global Clostridial Diseases Players Sales Volume Ranking (2023)
2.4 Global Clostridial Diseases Sales Volume by Company Players (2019-2024)
2.5 Global Clostridial Diseases Average Price by Company (2019-2024)
2.6 Key Manufacturers Clostridial Diseases Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Clostridial Diseases Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Clostridial Diseases
2.9 Clostridial Diseases Market Competitive Analysis
2.9.1 Clostridial Diseases Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Clostridial Diseases Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridial Diseases as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tetanus toxoid
3.1.2 Multivalent Vaccine
3.1.3 Antibiotics
3.2 Global Clostridial Diseases Sales Value by Type
3.2.1 Global Clostridial Diseases Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clostridial Diseases Sales Value, by Type (2019-2030)
3.2.3 Global Clostridial Diseases Sales Value, by Type (%) (2019-2030)
3.3 Global Clostridial Diseases Sales Volume by Type
3.3.1 Global Clostridial Diseases Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Clostridial Diseases Sales Volume, by Type (2019-2030)
3.3.3 Global Clostridial Diseases Sales Volume, by Type (%) (2019-2030)
3.4 Global Clostridial Diseases Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Humanity
4.1.2 Animal
4.2 Global Clostridial Diseases Sales Value by Application
4.2.1 Global Clostridial Diseases Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clostridial Diseases Sales Value, by Application (2019-2030)
4.2.3 Global Clostridial Diseases Sales Value, by Application (%) (2019-2030)
4.3 Global Clostridial Diseases Sales Volume by Application
4.3.1 Global Clostridial Diseases Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Clostridial Diseases Sales Volume, by Application (2019-2030)
4.3.3 Global Clostridial Diseases Sales Volume, by Application (%) (2019-2030)
4.4 Global Clostridial Diseases Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Clostridial Diseases Sales Value by Region
5.1.1 Global Clostridial Diseases Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clostridial Diseases Sales Value by Region (2019-2024)
5.1.3 Global Clostridial Diseases Sales Value by Region (2025-2030)
5.1.4 Global Clostridial Diseases Sales Value by Region (%), (2019-2030)
5.2 Global Clostridial Diseases Sales Volume by Region
5.2.1 Global Clostridial Diseases Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Clostridial Diseases Sales Volume by Region (2019-2024)
5.2.3 Global Clostridial Diseases Sales Volume by Region (2025-2030)
5.2.4 Global Clostridial Diseases Sales Volume by Region (%), (2019-2030)
5.3 Global Clostridial Diseases Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Clostridial Diseases Sales Value, 2019-2030
5.4.2 North America Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Clostridial Diseases Sales Value, 2019-2030
5.5.2 Europe Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Clostridial Diseases Sales Value, 2019-2030
5.6.2 Asia Pacific Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Clostridial Diseases Sales Value, 2019-2030
5.7.2 South America Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Clostridial Diseases Sales Value, 2019-2030
5.8.2 Middle East & Africa Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clostridial Diseases Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clostridial Diseases Sales Value
6.2.1 Key Countries/Regions Clostridial Diseases Sales Value, 2019-2030
6.2.2 Key Countries/Regions Clostridial Diseases Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Clostridial Diseases Sales Value, 2019-2030
6.3.2 United States Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clostridial Diseases Sales Value, 2019-2030
6.4.2 Europe Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clostridial Diseases Sales Value, 2019-2030
6.5.2 China Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clostridial Diseases Sales Value, 2019-2030
6.6.2 Japan Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clostridial Diseases Sales Value, 2019-2030
6.7.2 South Korea Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clostridial Diseases Sales Value, 2019-2030
6.8.2 Southeast Asia Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clostridial Diseases Sales Value, 2019-2030
6.9.2 India Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clostridial Diseases Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boehringer Ingelheim International GmbH
7.1.1 Boehringer Ingelheim International GmbH Company Information
7.1.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
7.1.3 Boehringer Ingelheim International GmbH Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boehringer Ingelheim International GmbH Clostridial Diseases Product Offerings
7.1.5 Boehringer Ingelheim International GmbH Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Introduction and Business Overview
7.2.3 Zoetis Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zoetis Clostridial Diseases Product Offerings
7.2.5 Zoetis Recent Development
7.3 Elanco
7.3.1 Elanco Company Information
7.3.2 Elanco Introduction and Business Overview
7.3.3 Elanco Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Elanco Clostridial Diseases Product Offerings
7.3.5 Elanco Recent Development
7.4 Merck & Co. Inc
7.4.1 Merck & Co. Inc Company Information
7.4.2 Merck & Co. Inc Introduction and Business Overview
7.4.3 Merck & Co. Inc Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck & Co. Inc Clostridial Diseases Product Offerings
7.4.5 Merck & Co. Inc Recent Development
7.5 Phibro Animal Health Corporation
7.5.1 Phibro Animal Health Corporation Company Information
7.5.2 Phibro Animal Health Corporation Introduction and Business Overview
7.5.3 Phibro Animal Health Corporation Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Phibro Animal Health Corporation Clostridial Diseases Product Offerings
7.5.5 Phibro Animal Health Corporation Recent Development
7.6 Virbac
7.6.1 Virbac Company Information
7.6.2 Virbac Introduction and Business Overview
7.6.3 Virbac Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Virbac Clostridial Diseases Product Offerings
7.6.5 Virbac Recent Development
7.7 Vetoquinol
7.7.1 Vetoquinol Company Information
7.7.2 Vetoquinol Introduction and Business Overview
7.7.3 Vetoquinol Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Vetoquinol Clostridial Diseases Product Offerings
7.7.5 Vetoquinol Recent Development
7.8 HIPRA
7.8.1 HIPRA Company Information
7.8.2 HIPRA Introduction and Business Overview
7.8.3 HIPRA Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.8.4 HIPRA Clostridial Diseases Product Offerings
7.8.5 HIPRA Recent Development
7.9 Ceva
7.9.1 Ceva Company Information
7.9.2 Ceva Introduction and Business Overview
7.9.3 Ceva Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Ceva Clostridial Diseases Product Offerings
7.9.5 Ceva Recent Development
7.10 Dechra
7.10.1 Dechra Company Information
7.10.2 Dechra Introduction and Business Overview
7.10.3 Dechra Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Dechra Clostridial Diseases Product Offerings
7.10.5 Dechra Recent Development
7.11 Kyoritsuseiyaku Corporation
7.11.1 Kyoritsuseiyaku Corporation Company Information
7.11.2 Kyoritsuseiyaku Corporation Introduction and Business Overview
7.11.3 Kyoritsuseiyaku Corporation Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Kyoritsuseiyaku Corporation Clostridial Diseases Product Offerings
7.11.5 Kyoritsuseiyaku Corporation Recent Development
7.12 Endovac Animal Health
7.12.1 Endovac Animal Health Company Information
7.12.2 Endovac Animal Health Introduction and Business Overview
7.12.3 Endovac Animal Health Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Endovac Animal Health Clostridial Diseases Product Offerings
7.12.5 Endovac Animal Health Recent Development
7.13 Zydus Group
7.13.1 Zydus Group Company Information
7.13.2 Zydus Group Introduction and Business Overview
7.13.3 Zydus Group Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Zydus Group Clostridial Diseases Product Offerings
7.13.5 Zydus Group Recent Development
7.14 Indian Immunologicals Pvt. Ltd
7.14.1 Indian Immunologicals Pvt. Ltd Company Information
7.14.2 Indian Immunologicals Pvt. Ltd Introduction and Business Overview
7.14.3 Indian Immunologicals Pvt. Ltd Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Indian Immunologicals Pvt. Ltd Clostridial Diseases Product Offerings
7.14.5 Indian Immunologicals Pvt. Ltd Recent Development
7.15 UCBVET Saúde e Bem Estar Animal
7.15.1 UCBVET Saúde e Bem Estar Animal Company Information
7.15.2 UCBVET Saúde e Bem Estar Animal Introduction and Business Overview
7.15.3 UCBVET Saúde e Bem Estar Animal Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.15.4 UCBVET Saúde e Bem Estar Animal Clostridial Diseases Product Offerings
7.15.5 UCBVET Saúde e Bem Estar Animal Recent Development
7.16 American Reagent Inc
7.16.1 American Reagent Inc Company Information
7.16.2 American Reagent Inc Introduction and Business Overview
7.16.3 American Reagent Inc Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.16.4 American Reagent Inc Clostridial Diseases Product Offerings
7.16.5 American Reagent Inc Recent Development
7.17 Neogen Corporation
7.17.1 Neogen Corporation Company Information
7.17.2 Neogen Corporation Introduction and Business Overview
7.17.3 Neogen Corporation Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Neogen Corporation Clostridial Diseases Product Offerings
7.17.5 Neogen Corporation Recent Development
7.18 Huvepharma
7.18.1 Huvepharma Company Information
7.18.2 Huvepharma Introduction and Business Overview
7.18.3 Huvepharma Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Huvepharma Clostridial Diseases Product Offerings
7.18.5 Huvepharma Recent Development
7.19 China Animal Husbandry Group
7.19.1 China Animal Husbandry Group Company Information
7.19.2 China Animal Husbandry Group Introduction and Business Overview
7.19.3 China Animal Husbandry Group Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.19.4 China Animal Husbandry Group Clostridial Diseases Product Offerings
7.19.5 China Animal Husbandry Group Recent Development
8 Industry Chain Analysis
8.1 Clostridial Diseases Industrial Chain
8.2 Clostridial Diseases Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clostridial Diseases Sales Model
8.5.2 Sales Channel
8.5.3 Clostridial Diseases Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Clostridial Diseases Market Trends
    Table 2. Clostridial Diseases Market Drivers & Opportunity
    Table 3. Clostridial Diseases Market Challenges
    Table 4. Clostridial Diseases Market Restraints
    Table 5. Global Clostridial Diseases Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Clostridial Diseases Revenue Market Share by Company (2019-2024)
    Table 7. Global Clostridial Diseases Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Clostridial Diseases Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Clostridial Diseases Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Clostridial Diseases Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Clostridial Diseases Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Clostridial Diseases
    Table 13. Global Clostridial Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridial Diseases as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Clostridial Diseases Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Clostridial Diseases Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Clostridial Diseases Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Clostridial Diseases Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Clostridial Diseases Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Clostridial Diseases Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Clostridial Diseases Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Clostridial Diseases Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Clostridial Diseases Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Clostridial Diseases Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Clostridial Diseases Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Clostridial Diseases Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Clostridial Diseases Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Clostridial Diseases Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Clostridial Diseases Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Clostridial Diseases Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Clostridial Diseases Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Clostridial Diseases Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Clostridial Diseases Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Clostridial Diseases Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Clostridial Diseases Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Clostridial Diseases Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Clostridial Diseases Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Clostridial Diseases Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Clostridial Diseases Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Clostridial Diseases Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Clostridial Diseases Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Clostridial Diseases Sales Value by Region (2019-2024) & (%)
    Table 44. Global Clostridial Diseases Sales Value by Region (2025-2030) & (%)
    Table 45. Global Clostridial Diseases Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Clostridial Diseases Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Clostridial Diseases Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Clostridial Diseases Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Clostridial Diseases Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Clostridial Diseases Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Clostridial Diseases Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Clostridial Diseases Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Clostridial Diseases Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Clostridial Diseases Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Clostridial Diseases Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Clostridial Diseases Sales Volume, (2025-2030) & (K Units)
    Table 57. Boehringer Ingelheim International GmbH Company Information
    Table 58. Boehringer Ingelheim International GmbH Introduction and Business Overview
    Table 59. Boehringer Ingelheim International GmbH Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Boehringer Ingelheim International GmbH Clostridial Diseases Product Offerings
    Table 61. Boehringer Ingelheim International GmbH Recent Development
    Table 62. Zoetis Company Information
    Table 63. Zoetis Introduction and Business Overview
    Table 64. Zoetis Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Zoetis Clostridial Diseases Product Offerings
    Table 66. Zoetis Recent Development
    Table 67. Elanco Company Information
    Table 68. Elanco Introduction and Business Overview
    Table 69. Elanco Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Elanco Clostridial Diseases Product Offerings
    Table 71. Elanco Recent Development
    Table 72. Merck & Co. Inc Company Information
    Table 73. Merck & Co. Inc Introduction and Business Overview
    Table 74. Merck & Co. Inc Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Merck & Co. Inc Clostridial Diseases Product Offerings
    Table 76. Merck & Co. Inc Recent Development
    Table 77. Phibro Animal Health Corporation Company Information
    Table 78. Phibro Animal Health Corporation Introduction and Business Overview
    Table 79. Phibro Animal Health Corporation Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Phibro Animal Health Corporation Clostridial Diseases Product Offerings
    Table 81. Phibro Animal Health Corporation Recent Development
    Table 82. Virbac Company Information
    Table 83. Virbac Introduction and Business Overview
    Table 84. Virbac Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Virbac Clostridial Diseases Product Offerings
    Table 86. Virbac Recent Development
    Table 87. Vetoquinol Company Information
    Table 88. Vetoquinol Introduction and Business Overview
    Table 89. Vetoquinol Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Vetoquinol Clostridial Diseases Product Offerings
    Table 91. Vetoquinol Recent Development
    Table 92. HIPRA Company Information
    Table 93. HIPRA Introduction and Business Overview
    Table 94. HIPRA Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. HIPRA Clostridial Diseases Product Offerings
    Table 96. HIPRA Recent Development
    Table 97. Ceva Company Information
    Table 98. Ceva Introduction and Business Overview
    Table 99. Ceva Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Ceva Clostridial Diseases Product Offerings
    Table 101. Ceva Recent Development
    Table 102. Dechra Company Information
    Table 103. Dechra Introduction and Business Overview
    Table 104. Dechra Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Dechra Clostridial Diseases Product Offerings
    Table 106. Dechra Recent Development
    Table 107. Kyoritsuseiyaku Corporation Company Information
    Table 108. Kyoritsuseiyaku Corporation Introduction and Business Overview
    Table 109. Kyoritsuseiyaku Corporation Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Kyoritsuseiyaku Corporation Clostridial Diseases Product Offerings
    Table 111. Kyoritsuseiyaku Corporation Recent Development
    Table 112. Endovac Animal Health Company Information
    Table 113. Endovac Animal Health Introduction and Business Overview
    Table 114. Endovac Animal Health Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Endovac Animal Health Clostridial Diseases Product Offerings
    Table 116. Endovac Animal Health Recent Development
    Table 117. Zydus Group Company Information
    Table 118. Zydus Group Introduction and Business Overview
    Table 119. Zydus Group Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Zydus Group Clostridial Diseases Product Offerings
    Table 121. Zydus Group Recent Development
    Table 122. Indian Immunologicals Pvt. Ltd Company Information
    Table 123. Indian Immunologicals Pvt. Ltd Introduction and Business Overview
    Table 124. Indian Immunologicals Pvt. Ltd Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Indian Immunologicals Pvt. Ltd Clostridial Diseases Product Offerings
    Table 126. Indian Immunologicals Pvt. Ltd Recent Development
    Table 127. UCBVET Saúde e Bem Estar Animal Company Information
    Table 128. UCBVET Saúde e Bem Estar Animal Introduction and Business Overview
    Table 129. UCBVET Saúde e Bem Estar Animal Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. UCBVET Saúde e Bem Estar Animal Clostridial Diseases Product Offerings
    Table 131. UCBVET Saúde e Bem Estar Animal Recent Development
    Table 132. American Reagent Inc Company Information
    Table 133. American Reagent Inc Introduction and Business Overview
    Table 134. American Reagent Inc Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. American Reagent Inc Clostridial Diseases Product Offerings
    Table 136. American Reagent Inc Recent Development
    Table 137. Neogen Corporation Company Information
    Table 138. Neogen Corporation Introduction and Business Overview
    Table 139. Neogen Corporation Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Neogen Corporation Clostridial Diseases Product Offerings
    Table 141. Neogen Corporation Recent Development
    Table 142. Huvepharma Company Information
    Table 143. Huvepharma Introduction and Business Overview
    Table 144. Huvepharma Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Huvepharma Clostridial Diseases Product Offerings
    Table 146. Huvepharma Recent Development
    Table 147. China Animal Husbandry Group Company Information
    Table 148. China Animal Husbandry Group Introduction and Business Overview
    Table 149. China Animal Husbandry Group Clostridial Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. China Animal Husbandry Group Clostridial Diseases Product Offerings
    Table 151. China Animal Husbandry Group Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Clostridial Diseases Downstream Customers
    Table 155. Clostridial Diseases Distributors List
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Clostridial Diseases Product Picture
    Figure 2. Global Clostridial Diseases Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Clostridial Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Clostridial Diseases Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Clostridial Diseases Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Clostridial Diseases Report Years Considered
    Figure 7. Global Clostridial Diseases Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Clostridial Diseases Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Clostridial Diseases Revenue in 2023
    Figure 10. Clostridial Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tetanus toxoid Picture
    Figure 12. Multivalent Vaccine Picture
    Figure 13. Antibiotics Picture
    Figure 14. Global Clostridial Diseases Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Clostridial Diseases Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Clostridial Diseases Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Clostridial Diseases Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Clostridial Diseases Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Humanity
    Figure 20. Product Picture of Animal
    Figure 21. Global Clostridial Diseases Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Clostridial Diseases Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Clostridial Diseases Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Clostridial Diseases Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Clostridial Diseases Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Clostridial Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Clostridial Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Clostridial Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Clostridial Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Clostridial Diseases Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Clostridial Diseases Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Clostridial Diseases Sales Volume (%), (2019-2030)
    Figure 38. United States Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Clostridial Diseases Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Clostridial Diseases Sales Value by Application (%), 2023 VS 2030
    Figure 59. Clostridial Diseases Industrial Chain
    Figure 60. Clostridial Diseases Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart